TW200509961A - Uses of interferons for the treatment of severe acute respiratory syndrome and other viral infections - Google Patents

Uses of interferons for the treatment of severe acute respiratory syndrome and other viral infections

Info

Publication number
TW200509961A
TW200509961A TW093114487A TW93114487A TW200509961A TW 200509961 A TW200509961 A TW 200509961A TW 093114487 A TW093114487 A TW 093114487A TW 93114487 A TW93114487 A TW 93114487A TW 200509961 A TW200509961 A TW 200509961A
Authority
TW
Taiwan
Prior art keywords
subject
treating
acute respiratory
respiratory syndrome
severe acute
Prior art date
Application number
TW093114487A
Other languages
English (en)
Inventor
Sidney Pestka
Thomas B Lavoie
William A Clark
Original Assignee
Pestka Biomedical Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pestka Biomedical Lab Inc filed Critical Pestka Biomedical Lab Inc
Publication of TW200509961A publication Critical patent/TW200509961A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW093114487A 2003-05-23 2004-05-21 Uses of interferons for the treatment of severe acute respiratory syndrome and other viral infections TW200509961A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47313403P 2003-05-23 2003-05-23

Publications (1)

Publication Number Publication Date
TW200509961A true TW200509961A (en) 2005-03-16

Family

ID=34272431

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093114487A TW200509961A (en) 2003-05-23 2004-05-21 Uses of interferons for the treatment of severe acute respiratory syndrome and other viral infections

Country Status (8)

Country Link
EP (1) EP1626734A2 (zh)
JP (1) JP2006526022A (zh)
CN (1) CN1832755A (zh)
AU (1) AU2004270102B2 (zh)
CA (1) CA2526428A1 (zh)
IL (1) IL171991A0 (zh)
TW (1) TW200509961A (zh)
WO (1) WO2005023290A2 (zh)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2292652A2 (en) * 2000-11-03 2011-03-09 Pestka Biomedical Laboratories, Inc. Interferons uses and compositions related thereto
CA2688693A1 (en) 2007-04-11 2008-10-23 Pestka Biomedical Laboratories, Inc. Interferons of rhesus and cynomolgus origin and uses thereof
US7625555B2 (en) * 2007-06-18 2009-12-01 Novagen Holding Corporation Recombinant human interferon-like proteins
DK2544705T3 (en) * 2010-03-12 2016-09-19 Synairgen Res Ltd INTERFERON BETA TO USE IN THE LOWER AIR TRANSMISSION CAUSED BY INFLUENZA
EP3095444A1 (en) 2015-05-20 2016-11-23 Dublin City University A method of treating peripheral inflammatory disease
EP3954700A1 (en) 2015-07-16 2022-02-16 Nuritas Limited Anti-inflammatory peptides derived from rice proteins (oryza sativa) and uses thereof
EP3118215A1 (en) 2015-07-16 2017-01-18 Nuritas Limited Anti-inflammatory peptides, and uses thereof
EP3118216A1 (en) 2015-07-16 2017-01-18 Nuritas Limited Cellular growth and proliferation promoting peptides, and uses thereof
EP3117831A1 (en) 2015-07-16 2017-01-18 Nuritas Limited Peptides for use in promoting transport of glucose into skeletal muscle
EP3117830A1 (en) 2015-07-16 2017-01-18 Nuritas Limited Antibacterial peptides, and uses thereof
WO2018014936A1 (en) 2016-07-18 2018-01-25 Nuritas Limited Topical compositions
EP3329905A1 (en) 2016-12-05 2018-06-06 Nuritas Limited Topical cosmetic compositions comprising an oligopeptide against anti-aging of the skin
AU2017373651B2 (en) 2016-12-05 2022-03-10 Nuritas Limited Compositions comprising peptide wkdeagkplvk
CN108721603B (zh) * 2017-04-14 2020-11-13 中国医学科学院基础医学研究所 干扰素α-1a在制备用于治疗癌症的药物中的用途
US11760963B2 (en) 2017-08-23 2023-09-19 KetoneAid Inc. Ketogenic beer and alcoholic beverage mixture containing non-racemic ethyl 3-hydroxybutyrate and/or 1,3 butanediol
EP3783012A1 (en) 2019-08-20 2021-02-24 Nuritas Limited An antimicrobial peptide
WO2021032650A1 (en) 2019-08-20 2021-02-25 Nuritas Limited Peptides for treating muscle atrophy
WO2021058492A1 (en) 2019-09-25 2021-04-01 University College Dublin Nanoparticle compositions for gene therapy
JP2022553367A (ja) 2019-10-22 2022-12-22 ニューリタス リミテッド 非アルコール性脂肪肝の治療
EP3862014A1 (en) 2020-02-07 2021-08-11 Nuritas Limited Treatment of panx1 associated diseases
CN113425832A (zh) * 2020-03-23 2021-09-24 杭州先为达生物科技有限公司 干扰素λ在新型冠状病毒(2019-nCoV)感染治疗中的应用
WO2021195477A1 (en) * 2020-03-27 2021-09-30 Ketoneaid, Inc. Ketone ester as a therapeutic treatment of covid-19, long covid, and related viral infections
WO2021236614A1 (en) * 2020-05-18 2021-11-25 Northwestern University Targeted antiviral drugs
WO2022079205A1 (en) * 2020-10-15 2022-04-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of ifn-alpha polypeptides for the treatment of coronavirus infections
WO2023131648A1 (en) 2022-01-05 2023-07-13 Branca Bunus Limited Nanoparticulate compositions for gene therapy
CN114533706B (zh) * 2022-02-15 2022-10-14 深圳市利云德生物技术有限公司 一种用于防治呼吸道疾病的雾化吸入制剂及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3891600A (en) * 1999-03-18 2000-10-04 Zymogenetics Inc. Murine interferon-alpha named also zcyto13
EP1237546A2 (en) * 1999-10-01 2002-09-11 Institute of Molecular and Cell Biology Dihydroorotate dehydrogenase inhibitors for the treatment of viral-mediated diseases
WO2002015664A2 (en) * 2000-08-23 2002-02-28 The New York Hospital Medical Center Of Queens Methods of preventing or treating west nile virus and other infections
EP2292652A2 (en) * 2000-11-03 2011-03-09 Pestka Biomedical Laboratories, Inc. Interferons uses and compositions related thereto

Also Published As

Publication number Publication date
JP2006526022A (ja) 2006-11-16
AU2004270102A1 (en) 2005-03-17
AU2004270102B2 (en) 2009-10-01
WO2005023290A3 (en) 2005-12-22
WO2005023290A2 (en) 2005-03-17
CN1832755A (zh) 2006-09-13
IL171991A0 (en) 2011-08-01
EP1626734A2 (en) 2006-02-22
CA2526428A1 (en) 2005-03-17

Similar Documents

Publication Publication Date Title
TW200509961A (en) Uses of interferons for the treatment of severe acute respiratory syndrome and other viral infections
BR0111195A (pt) Uso de b-l-2'-desoxi-nucleosìdeos no tratamento de infecção por vìrus de hepatite delta
WO2022217155A3 (en) Thionucleosides as antiviral agents
EA200201279A1 (ru) Способы и композиции для лечения вирусного гепатита c
MY141594A (en) 3'-PRODRUGS OF 2'-DEOXY-ß-L-NUCLEOSIDES
TW200733953A (en) Materials and methods for treating viral infections
TW200633995A (en) Andrographolide derivatives to treat viral infections
HUP0401818A2 (hu) Eljárás hepatitis vírusfertőzés kezelésére multifázisos interferon felszabadulású profillal
ATE500808T1 (de) Onkolytische virustherapie
WO2006050489A3 (en) Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions
ATE476983T1 (de) Immunostimulierende polynukleotide sequenzen zur verwendung bei der verhinderung und behandlung von viralen erkrankungen der atemwege
EP0652011A4 (en) PROPHYLACTIC AGENT AND CURATIVE AGENT AGAINST VIRAL DISEASES OF THE RESPIRATORY TRACT.
DE60237721D1 (de) Kombinationstherapie mit omega-interferon zur behandlung von hepatitis c virus oder gelbfieber virus infektionen
MXPA05005203A (es) Vacuna contra vhc.
NO20055512L (no) Terapi eller prevensjon av respiratoriske, virale infeksjoner med alfa-tyimosinpeptider
DE602005016552D1 (de) Parapocken-viren in kombination mit anderen antiviralen mitteln zur behandlung von hiv/aids
MX2023000242A (es) Reduccion de infecciones virales.
NO20055243L (no) Interferon beta ved alvorlig akutt respiratorisk syndrom (SARS)
WO2003037265A3 (en) Method of treating viral infections
WO2002015664A3 (en) Methods of preventing or treating west nile virus and other infections
UA95299C2 (ru) Профилактический или терапевтический агент против вирусного заболевания, вызванного вирусом гепатита с
WO2004006848A3 (en) Combination therapies with ftc for the treatment of hepatitis b virus infection
BR112022006913A2 (pt) Métodos para tratar infecções virais de hepatite delta
BR0008269A (pt) Uso de uma preparação de m. vaccae, e, método para tratamento de infecção viral crÈnica, excluindo infecção por hiv
WO2004108756A3 (en) Sars coronavirus peptides and uses thereof